Showing all 3 results
Leflunomide Tablets
FreeProduct Composition & Available Portfolio Strengths
We supply Leflunomide across the complete compendial strength matrix, enabling clinicians to manage both rapid initial loading cycles and long-term low-dose maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Leflunomide USP / BP / IP 10 mg Oral Solid Film-Coated Tablet Low-Dose Maintenance: Calibrated for mild-to-moderate maintenance blocks or patients exhibiting sensitive hepatic profiles. Leflunomide USP / BP / IP 20 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard daily maintenance dose for active Rheumatoid and Psoriatic Arthritis. Leflunomide USP / BP / IP 100 mg Oral High-Mass Solid Tablet Initial Loading Regimen: High-potency format utilized exclusively for the rapid 3-day initial tissue saturation phase. Methotrexate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Isotonic Solution (Ready-to-Use) or Lyophilized Powder (High Dose).
Active Ingredient Strength Common Application Methotrexate USP/BP 2.5 mg / ml Low Dose (Rheumatology/Dermatology) Methotrexate USP/BP 25 mg / ml Standard Oncology Dose Methotrexate USP/BP 50 mg / 500 mg / 1 g High Dose MTX (Leukemia Protocols) Preservative Benzyl Alcohol Present in Multi-dose Vials (Avoid in IT use) *Pack Sizes: 2 ml Vial, 20 ml Vial, or 50 ml Vial.
Methotrexate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite.
Active Ingredient Strength Primary Clinical Function Methotrexate USP/Ph.Eur. 2.5 mg Global Autoimmune Standard: The absolute foundational unit for Rheumatoid Arthritis and Psoriasis, allowing for highly precise, incremental dose titration. Methotrexate USP/Ph.Eur. 5 mg / 7.5 mg / 10 mg Escalated / Oncology Standard: Higher-dose units for severe, refractory autoimmune disease, Choriocarcinoma, and maintenance therapy in Acute Lymphoblastic Leukemia (ALL). Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, heavily monitored chronic dispensing regimens).
